There is clear manipulation going on here. Bottom line is that after they announce IDE has been approved, highly likely that any institutional investors who are on the sidelines will buy in. Would be stupid to sell if you believe in the company's therapy, and if you believe IDE will get accepted. Don't let any of this rattle your conviction. We are literally sitting in the best position for success in the last 5 years
Market Data 
Markets 
AI
